Regeneron Gives Statement on Stock Halt, Cites FDA Meeting For Praluent Today
June 09, 2015 at 07:08 AM EDT
Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced that NASDAQ has halted trading of the company's common stock. The ...